Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

: Niemann CU, Levin MD, Dubois J, Kersting S, Enggaard L, Veldhuis GJ, Mous R, Mellink CHM, Dobber JA, Poulsen CB, Frederiksen H, Janssens A, Schjødt I, Dompeling EC, Ranti J, Bellido M, Mattsson M, Nasserinejad K, Tran HTT, Kater AP

: 2021

: Blood

: 0006-4971

: 1528-0020

DOI: https://doi.org/10.1182/blood.2020008608